A Revolution in Treatment for Hepatitis C Infection: Mitigating the Budgetary Impact.

Clicks: 189
ID: 69173
2016
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
In a Perspective accompanying Hill and colleagues, Elliot Marseille and James Kahn compare the history of pricing and availability of ART for HIV with that of the new HCV drugs and discuss strategies for providing treatment in LMIC even in the face of high costs.
Reference Key
marseille2016aplos Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Marseille, Elliot;Kahn, James G;
Journal plos medicine
Year 2016
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.